Security key
76155X118
Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW)
CUSIP: 76155X118
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / *W EXP 12/17/202
- Total 13F shares
- 4,907,148
- Share change
- +4,830,148
- Total reported value
- $1,621,737
- Price per share
- $0.33
- Number of holders
- 19
- Value change
- +$1,596,327
- Number of buys
- 18
Report period
Q4 2023
Institutions
19
Top holders
10
RVMDW full security history
Newer quarter: Q1 2024
Revolution Medicines, Inc. SEC filings
Revolution Medicines, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76155X118
Recent filing periods:
Top shareholders of RVMDW - Revolution Medicines, Inc. - *W EXP 12/17/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.3%
|
10,572,475
|
$292,646,109 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.8%
|
9,643,591
|
$266,934,599 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.5%
|
8,871,414
|
$245,560,740 | — | 30 Sep 2023 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.8%
|
5,577,863
|
$154,395,248 | — | 30 Sep 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.6%
|
5,094,706
|
$141,023,000 | — | 30 Sep 2023 | |
| Nextech Invest Ltd. |
13F
|
Company |
2.4%
|
4,839,529
|
$133,958,163 | — | 30 Sep 2023 | |
| Bellevue Group AG |
13F
|
Company |
2.4%
|
4,721,500
|
$130,691,120 | — | 30 Sep 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
2.4%
|
4,684,264
|
$129,660,428 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.1%
|
4,279,919
|
$118,468,158 | — | 30 Sep 2023 | |
| BVF INC/IL |
13F
|
Company |
2%
|
3,981,212
|
$110,199,948 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
1.9%
|
3,867,610
|
$107,055,445 | — | 30 Sep 2023 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.7%
|
3,325,480
|
$92,049,286 | — | 30 Sep 2023 | |
| Woodline Partners LP |
13F
|
Company |
1.6%
|
3,145,445
|
$87,065,918 | — | 30 Sep 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.4%
|
2,691,493
|
$74,500,526 | — | 30 Sep 2023 | |
| Artal Group S.A. |
13F
|
Company |
1.3%
|
2,529,737
|
$70,023,000 | — | 30 Sep 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.1%
|
2,240,739
|
$62,029,687 | — | 30 Sep 2023 | |
| Holocene Advisors, LP |
13F
|
Company |
1.1%
|
2,190,722
|
$60,639,185 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
2,072,732
|
$57,380,292 | — | 30 Sep 2023 | |
| Casdin Capital, LLC |
13F
|
Company |
0.91%
|
1,810,000
|
$50,100,800 | — | 30 Sep 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.88%
|
1,751,496
|
$48,481,409 | — | 30 Sep 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.83%
|
1,661,863
|
$46,003,069 | — | 30 Sep 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.66%
|
1,321,795
|
$36,587,286 | — | 30 Sep 2023 | |
| Column Group LLC |
13F
|
Company |
0.62%
|
1,230,641
|
$34,064,143 | — | 30 Sep 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.61%
|
1,211,856
|
$33,544,183 | — | 30 Sep 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.5%
|
997,455
|
$27,609,554 | — | 30 Sep 2023 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.48%
|
962,657
|
$26,646,346 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.47%
|
933,125
|
$25,828,900 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.4%
|
801,973
|
$22,198,612 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.38%
|
766,669
|
$21,221,398 | — | 30 Sep 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.37%
|
745,271
|
$20,629,102 | — | 30 Sep 2023 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.36%
|
725,152
|
$20,072,207 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
0.35%
|
698,818
|
$19,343,282 | — | 30 Sep 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
0.33%
|
657,200
|
$18,191,296 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.31%
|
627,445
|
$17,367,678 | — | 30 Sep 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.28%
|
561,948
|
$15,554,721 | — | 30 Sep 2023 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.26%
|
525,000
|
$14,532,000 | — | 30 Sep 2023 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.24%
|
473,394
|
$13,103,546 | — | 30 Sep 2023 | |
| NORGES BANK |
13F
|
Company |
0.22%
|
439,687
|
$12,170,536 | — | 30 Sep 2023 | |
| Finepoint Capital LP |
13F
|
Company |
0.21%
|
427,000
|
$11,819,360 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.21%
|
420,366
|
$11,635,732 | — | 30 Sep 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
361,000
|
$9,992,480 | — | 30 Sep 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.17%
|
342,359
|
$9,476,498 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.14%
|
274,945
|
$7,610,477 | — | 30 Sep 2023 | |
| MPM BioImpact LLC |
13F
|
Company |
0.14%
|
273,408
|
$7,567,933 | — | 30 Sep 2023 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.14%
|
271,824
|
$7,524,088 | — | 30 Sep 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.13%
|
256,043
|
$7,087,270 | — | 30 Sep 2023 | |
| Logos Global Management LP |
13F
|
Company |
0.13%
|
250,000
|
$6,920,000 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.12%
|
247,816
|
$6,859,547 | — | 30 Sep 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
246,458
|
$6,821,957 | — | 30 Sep 2023 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.12%
|
243,442
|
$6,738,000 | — | 30 Sep 2023 |
Institutional Holders of Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) as of Q4 2023
As of 31 Dec 2023,
Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,907,148 shares.
The largest 10 holders included
D. E. Shaw & Co., Inc., PRICE T ROWE ASSOCIATES INC /MD/, Walleye Capital LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., SOROS CAPITAL MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, Bleichroeder LP, COWEN AND COMPANY, LLC, Sculptor Capital LP, and DAVIDSON KEMPNER CAPITAL MANAGEMENT LP.
This page lists
19
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q4 2025 Across Filers
Q4 2025 holders
22
Q4 2023 holders
19
Holder diff
-3
| Investor | Q4 2025 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.